Imaging features of gastrointestinal toxicity in non-small cell lung cancer patients treated with erlotinib: A single institute 13-year experience.

o.lakala70 shared this article with you from Inoreader Imaging features of gastrointestinal toxicity in non-small cell lung cancer patients treated with erlotinib: A single institute 13-year experience. Via MedWorm Cancer & Oncology Research CONCLUSION: Erlotinib-associated GT was identified in 15% patients with NSCLC. Fluid-filled colon and segmental involvement were the most common imaging manifestations. PMID: 32892106 [PubMed - indexed for MEDLINE] (Source: Clinical Lung Cancer) View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.